4//SEC Filing
Dunne Michael W. 4
Accession 0001209191-23-022422
CIK 0001659323other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:00 PM ET
Size
7.5 KB
Accession
0001209191-23-022422
Insider Transaction Report
Form 4
Dunne Michael W.
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-04-01+1,299→ 37,636 total - Exercise/Conversion
Restricted Share Units
2023-04-01−1,299→ 0 total→ Ordinary Shares (1,299 underlying)
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On June 25, 2022, the reporting person was granted an award of 1,299 RSUs, which vested in full on April 1, 2023.
- [F3]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001553593
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:00 PM ET
- Size
- 7.5 KB